Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN, July 17, 2024 DUBLIN...
Alkermes Presents Data From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With...
Alkermes to Participate in Two Upcoming Investor Conferences PR Newswire DUBLIN, May 29, 2024 DUBLIN, May 29...
Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024 PR Newswire DUBLIN, May 28, 2024 –...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.